Community protocols describe keeping fast-acting carbohydrates available hypoglycemia is the most immediate risk
The authors suggest that closer monitoring may be warranted for patients prescribed GLP-1 RAs, particularly those with personal or family histories of autoimmune disease
Among both patients and physicians, Prefer oral medication over injections was the most common issue with GLP1 RAs, although this concern was reported by 56% of patients and only 33% of physicians (Figure 3A)
Obesity pathophysiology and metabolic science: Understanding the hormonal, neurological, and genetic factors that drive weight gain and resist weight loss GLP-1 receptor agonist mastery: Comprehensive training on semaglutide, tirzepatide, and emerging agents, including prescribing protocols, titration schedules, contraindication screening, and side effect management Comprehensive pharmacotherapy: Phentermine, phentermine-topiramate, naltrexone-bupropion, orlistat, metformin, and combination strategies Peptide therapy and compounded medications: Navigating the regulatory and clinical landscape for compounded semaglutide and adjunctive peptides Metabolic testing and body composition analysis: Hands-on training with indirect calorimetry, DEXA scanning, and bioimpedance analysis Nutritional programming: Developing individualized meal plans, protein optimization for lean mass preservation, and supplement protocols Behavioral health integration: Practical CBT and motivational interviewing techniques for the clinical weight management setting Business and practice operations: Program pricing, patient acquisition, billing and coding, staff training, and scaling strategies Why AAOPM The AAOPM approach to medical weight loss certification is distinguished by its emphasis on immediate clinical applicability
Can Kratom Kill You
Individual responses vary substantially based on baseline metabolism and hormonal status
/assets/images/provider/photos/2702244.jpeg)
